Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CO3 pseudogene 9 (MTCO3P9) is classified as a pseudogene related to the mitochondrial gene encoding cytochrome c oxidase subunit III. Pseudogenes are typically non-functional genomic sequences resembling known genes but lacking protein-coding potential due to mutations or loss of regulatory elements. As a pseudogene, MTCO3P9 does not encode an active protein, is not involved in biological pathways, and is not considered a therapeutic or biological target[2]. No evidence supports any role for MTCO3P9 in drug interactions, mechanisms of action, disease association, or biomarker use[2]. It is listed in gene databases as a pseudogene and not an active target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CO3 pseudogene 9 (MTCO3P9).